Teacher Retirement System of Texas Grows Position in Option Care Health, Inc. (NASDAQ:OPCH)

Teacher Retirement System of Texas grew its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 73.0% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 107,644 shares of the company's stock after buying an additional 45,431 shares during the period. Teacher Retirement System of Texas owned 0.07% of Option Care Health worth $3,762,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Allspring Global Investments Holdings LLC boosted its holdings in shares of Option Care Health by 6,525,926.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 1,500,986 shares of the company's stock valued at $52,459,000 after buying an additional 1,500,963 shares in the last quarter. Bessemer Group Inc. boosted its holdings in shares of Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after buying an additional 599 shares in the last quarter. Wealthquest Corp acquired a new stake in Option Care Health in the 1st quarter worth approximately $66,000. Sheets Smith Wealth Management boosted its stake in Option Care Health by 2.6% in the 1st quarter. Sheets Smith Wealth Management now owns 24,481 shares of the company's stock worth $856,000 after purchasing an additional 625 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its stake in Option Care Health by 33.0% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 49,132 shares of the company's stock worth $1,717,000 after purchasing an additional 12,180 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on OPCH shares. Barrington Research reiterated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research note on Wednesday, June 18th. Finally, UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH traded down $0.06 during trading on Tuesday, hitting $30.85. 1,315,368 shares of the stock traded hands, compared to its average volume of 1,859,988. The company has a quick ratio of 1.02, a current ratio of 1.54 and a debt-to-equity ratio of 0.82. The company has a market cap of $5.05 billion, a price-to-earnings ratio of 24.88, a P/E/G ratio of 1.88 and a beta of 0.73. The company has a fifty day moving average price of $31.93 and a two-hundred day moving average price of $31.26. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The firm's revenue was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.26 EPS. As a group, equities analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.